ofloxacin has been researched along with pazufloxacin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fukuda, Y; Fukuoka, Y; Muratani, T; Narita, H; Takahata, M; Watanabe, Y; Yasuda, T | 1 |
| Hayakawa, H; Hayashi, K; Ishikura, H; Nakafuku, K; Nakajima, Y; Oishi, M; Takano, Y | 1 |
| Fukuoka, Y; Ikeda, Y; Narita, H; Takahata, M; Todo, Y; Yamashiro, Y | 1 |
| Araki, H; Minami, S; Narita, H; Ogake, N; Tamai, I; Tsuji, A; Watanabe, Y | 1 |
| Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
| Hayakawa, H; Kawamura, Y; Takagi, K; Takano, YF; Tsuji, A | 1 |
| Baeyens, WR; Ouyang, J; Yang, Y; Zhao, H; Zhou, S | 1 |
| Fan, Y; Gan, X; Li, S; Qin, W | 1 |
| Ito, K; Izumi, K; Mikamo, H; Tamaya, T; Tanaka, K; Watanabe, K | 1 |
| Baeyens, WR; Fei, G; He, L; Huang, C; Ouyang, J; Wang, Y | 1 |
| Kim, J; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Hiraoka, R; Nakazawa, K; Shinozaki, K; Suzuki, Y; Takeshita, K; Watabe, S; Yokoyama, Y | 1 |
| Drlica, K; German, N; Kerns, RJ; Malik, M; Marks, KR; Schwanz, HA | 1 |
1 trial(s) available for ofloxacin and pazufloxacin
| Article | Year |
|---|---|
[Effectiveness of switch therapy for peritonitis].
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Health Care Costs; Humans; Injections, Intravenous; Meropenem; Middle Aged; Naphthyridines; Ofloxacin; Oxazines; Peritonitis; Thienamycins | 2007 |
13 other study(ies) available for ofloxacin and pazufloxacin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Mechanism of renal excretion of T-3761, a novel fluoroquinolone agent, in rabbits].
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Half-Life; Kidney; Male; Ofloxacin; Oxazines; Probenecid; Rabbits | 1995 |
[Affinity of T-3761 to ocular melanin and intraocular dynamics].
Topics: Animals; Anti-Infective Agents; Eye; Fluoroquinolones; Melanins; Ofloxacin; Oxazines; Rabbits | 1995 |
In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Lung Diseases; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Urinary Tract Infections | 1993 |
Application of muscle microdialysis to evaluate the concentrations of the fluoroquinolones pazufloxacin and ofloxacin in the tissue interstitial fluids of rats.
Topics: Animals; Anti-Infective Agents; Extracellular Space; Fluoroquinolones; Male; Microdialysis; Muscles; Ofloxacin; Oxazines; Rats; Rats, Wistar; Tissue Distribution | 1997 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Chromatography, High Pressure Liquid; Fluoroquinolones; Male; Metabolic Clearance Rate; Muscle, Smooth; Ofloxacin; Oxazines; Protein Binding; Rats; Rats, Wistar; Tissue Distribution | 2002 |
Chiral separation of four fluoroquinolone compounds using capillary electrophoresis with hydroxypropyl-beta-cyclodextrin as chiral selector.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Electrophoresis, Capillary; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Molecular Structure; Ofloxacin; Oxazines; Quinolones; Stereoisomerism | 2006 |
A rapid CE-potential gradient detection method for determination of quinolones.
Topics: Animals; Electrophoresis, Capillary; Enoxacin; Fleroxacin; Fluoroquinolones; Methods; Milk; Ofloxacin; Oxazines; Quinolones | 2007 |
Enhanced separation of seven quinolones by capillary electrophoresis with silica nanoparticles as additive.
Topics: Buffers; Electrophoresis, Capillary; Fleroxacin; Fluoroquinolones; Gatifloxacin; Nanoparticles; Ofloxacin; Oxazines; Quinolones; Silicon Dioxide | 2009 |
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Dioxolanes; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Phenylacetates; Piperazines; Receptors, GABA-A; Seizures | 2009 |
Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Humans; Least-Squares Analysis; Levofloxacin; Ofloxacin; Oxazines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2010 |
Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality.
Topics: Anti-Infective Agents; Chloramphenicol; Escherichia coli; Fluoroquinolones; Levofloxacin; Ofloxacin; Oxazines; Structure-Activity Relationship | 2010 |